Reengineering the immune system to kill cancer
Does cancer immunotherapy work better in men than women?
Gene expression fails to adapt in night shift workers
3D 'mini brains' shed new light on mental illness
Garvan researchers find a new form of DNA
Reengineering the immune system to kill cancer
CAR-T immunotherapy has the potential to revolutionise the way certain cancers are treated but challenges associated with cost and complexity of these therapies have...
'Bystander killing' eliminates rogue cancer cells
Scientists have identified a previously underappreciated way that cancer cells are destroyed — the inflammatory cytokine known as tumour necrosis factor (TNF).
'Non-functioning' genes play their part in cancer research
Scientists have investigated a special class of genes known as noncoding RNAs, found in the human genome and previously thought to be 'non-functioning' in cancer...
Programmed cell death not as vital as originally thought
While programmed cell death is essential for healthy development overall, many organs and tissues do not require the process in order to develop normally.
Microbiome research to aid malnourished children
A collaboration between Merck and Washington University in St. Louis could lead to the optimising of nutritional supplements to restore a healthy gut microbiome.
Reengineering the immune system to kill cancer
CAR-T immunotherapy has the potential to revolutionise the way certain cancers are treated but challenges associated with cost and complexity of...
-
Australia's biotech boom to continue
The Australian life sciences and biotech industry is witnessing a resurgence in activity, which...
-
-
Modular hearing aids: functional, rechargeable, beautiful
A Melbourne researcher has helped design what is claimed to be the world's first modular...
-
-
'Thought control' enables spinal injury patient to ride a bike
Gold Coast researchers are using a 3D computer-simulated biomechanical model and an...
-
Does cancer immunotherapy work better in men than women?
Male cancer patients may benefit more from immunotherapy than female patients.
-
Drug delays disability in secondary progressive MS
A new drug is said to slow the progression of disability in secondary progressive multiple...
-
-
Alzheimer's blood test predicts beta-amyloid in the brain
Scientists have discovered plasma biomarkers that can predict beta-amyloid deposition in the...
-
-
Gene therapy comes of age
Gene therapy is no longer the future of medicine, but is part of the present-day clinical...
-
3D 'mini brains' shed new light on mental illness
US researchers are using 'mini brains', cultured from human stem cells, to study mutations in the gene most commonly associated with mental...
-
Garvan researchers find a new form of DNA
In a world first, researchers from the Garvan Institute of Medical Research have identified a new...
-
-
Bad immune cells can turn good
Scientists have discovered that cells once thought to be useful, and even a liability, could be...
-
-
Scientists 'reverse' ageing in mice by improving endurance
Replacing two naturally occurring molecules in the body could reverse symptoms of ageing,...
-
Gene expression fails to adapt in night shift workers
Researchers recently revealed the impact that a four-day simulation of night shift work had on the expression of 20,000 genes.
-
CRISPR gene-editing tool targets RNA, tackles dementia
Scientists have used CRISPR gene-editing technology to target RNA — as opposed to DNA...
-
-
DNA scissors can cut RNA as well
Scientists have discovered that Cas9 'DNA scissors' can also readily target RNA, in a...
-
-
Modified gene-editing technique reverses disease without cutting DNA
Californian researchers have developed a modified CRISPR-Cas9 technique that alters the activity,...
-
Award-winning digital innovations for the health sector
The winning entries in the 2015 national iAwards have brought a range of benefits to a variety of sectors — with the health sector being no...
-
From little grants big labs grow
The Monash Institute of Pharmaceutical Sciences has officially opened its new laboratory —...
-
-
A non-exclusive licence agreement for LBT and bioMérieux
LBT Innovations and bioMérieux have converted their exclusive licence...
-
-
UTS opens state-of-the-art health and science building
UTS's Faculty of Science and Graduate School of Health Building - the third major development...
-
